Metacognitive Therapy for Depression and Generalized Anxiety Disorder in Primary Care, Blended Version of Mediated Treatment

Study 1. Feasibility study: Outcome measures of acceptability, feasibility and compliance: a. What percentage of surveyed patients choose to participate in bMCT? b. What is the dropout rate, given reasons for dropping out? c. How many modules do the patients complete, from 1 to 8? d. patient satisfaction with treatment (Client Satisfaction Questionnaire, CSQ-8, range from 8 low satisfaction to 32 high satisfaction) d. Any reported negative effects of treatment e. Adherence and competence in delivering MCT sessions (MCT-Competence Scale, MCT-CS, 18 items, scale 0-5) Study1: Experience and Usability, qualitative method: 1. How are bMCT and treatment materials experienced by patients and therapists respectively? 2. What facilitates and hinders the implementation of bMCT? Study1: Preliminary clinical effects: 1. symptoms of depression (PHQ-9, 0-27), symptoms of GAD (PSWQ, 16-80) 2. quality of life (5-item Satisfaction with Life Scale, SWLS, 0-35) d. functional level (WHO Disability Assessment Schedule 2.0, WHODAS, 0-48) e. self-assessed ability to work (Work Ability Index, WAI 0-10) Study 2: randomized controlled study, additional measurements of acceptability, feasibility, compliance: Varies 1. proportion completed modules between groups? 2. percentage dropouts between groups? 3. therapist competence and adherence to MCT between groups? 4. patient satisfaction with treatment (CSQ-8, range from 8 low satisfaction to 32 high satisfaction)